# NORTH CHINA Digital Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/north-china-digital-health

- Industry: Healthcare IT
- Headquarters: Jinan, China
- Website: www.cnhealth.com
- Latest round: Series A (Oct 8, 2023)
- Investors on record: 7

## About

Based in China, NORTH CHINA Digital Health specializes in health medical big data services, providing comprehensive solutions to enhance healthcare operations and data management for various stakeholders.NORTH CHINA Digital Health, founded in 2020, operates from Jinan, China, focusing on data services for the healthcare sector. The company has completed a total of 3 deals, with the most recent deal occurring on October 9, 2023. Details about the founder are not available, and there is no mention of subsidiary relationships or significant business strategy shifts.NORTH CHINA Digital Health offers a broad array of health medical big data services, operating under the National Health Commission of China. Their products cater to the healthcare sector, featuring data storage, integration, governance, and operational solutions. The company's offerings include health cloud services, intelligent technology services, and data element services aimed at enhancing clinical research, new drug development, and health insurance operations. By leveraging AI, blockchain, and privacy computing, they develop a unified data platform for processing, analyzing, and applying health data across various scenarios, primarily serving government bodies, healthcare institutions, and wellness organizations in Shandong province and throughout China.The revenue model of NORTH CHINA Digital Health is centered on B2B partnerships, collaborating with healthcare providers and governmental agencies to provide data services. Their business structure typically involves contractual agreements for cloud services, disaster recovery solutions, and custom data analytics tailored to client needs, utilizing subscription-based models or project contracts that involve ongoing service delivery. While specific pricing details are not disclosed, the company focuses on catering to public health sectors, hospitals, and research institutions, thus establishing a diverse revenue base driven by the demand for enhanced healthcare data capabilities.Following the recent exit of Shandong Financial Development from its stake in NORTH CHINA Digital Health in October 2023, the company plans to use the insights gained from this transition to refine its strategic initiatives. The firm is exploring opportunities to introduce new products aimed at expanding its service offerings, though specific launch dates are not mentioned. Additionally, there are plans for geographic expansion beyond Shandong province to other regions in China, aiming to enhance its market presence by the end of 2024.

## Funding rounds

- Series A, Oct 8, 2023 — Inspur Capital
- Angel, Jul 16, 2020 — Shandong Buchang Pharmaceuticals Co., Ltd., Shandong Guohui Capital, Shandong Financial Development, Dareway Software Co.,Ltd., Shandong Xinhua Pharmaceutical Co., Ltd., Shandong Development & Investment Holding Group Co.,Ltd.

## Investors

- Shandong Buchang Pharmaceuticals Co., Ltd. — Angel
- Shandong Guohui Capital (https://capitalatlas.ai/funds/shandong-guohui-capital) — Angel
- Shandong Financial Development — Angel
- Dareway Software Co.,Ltd. — Angel
- Shandong Xinhua Pharmaceutical Co., Ltd. — Angel
- Shandong Development & Investment Holding Group Co.,Ltd. — Angel
- Inspur Capital (https://capitalatlas.ai/funds/inspur-capital) — Series A